Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases

TH Liu, JY Wu, PY Huang, WH Hsu… - Expert Review of Anti …, 2024 - Taylor & Francis
Background This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV-r) in
treating patients with COVID-19 who have preexisting cardiovascular diseases (CVDs) …
被引用次数：3 相关文章

Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases

TH Liu, JY Wu, PY Huang, WH Hsu… - Expert review of anti … - pubmed.ncbi.nlm.nih.gov
Background This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV-r) in
treating patients with COVID-19 who have preexisting cardiovascular diseases (CVDs) …

Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases.

TH Liu, JY Wu, PY Huang, WH Hsu… - Expert Review of Anti …, 2023 - europepmc.org
This study assessed the clinical efficacy of nirmatrelvir plus ritonavir (NMV-r) in treating
patients with COVID-19 who have preexisting cardiovascular diseases (CVDs). Patients with …